SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

USFDA completes inspection at Solara Active Pharma’s Chennai facility

15 Dec 2018 Evaluate

Solara Active Pharma Science has successfully completed the US Food and Drug Administration’s (USFDA) inspection at Solara Research Centre (SRC), Chennai with zero 483s inspectional observations.

The centre is equipped with high-end infrastructure with advanced analytical capabilities, strong IP assessment skills and global regulatory expertise. SRC is also an important pivot in Solara's Contract Research and manufacturing services (CRAMS) vertical.

Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.

Solara Active Pharma Share Price

491.95 -7.30 (-1.46%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×